Syntavit recently raised 5,25 MNOK in new equity, bringing Kistefos onboard as a new lead investor in addition to Springfondet and Synthetica. The round also included investments from employees and board members.
Syntavit has also recently strengthened its board of directors by appointing Mrs. Kimberly Lei as a new board member. Kimberly is the General Manager of Lilly in Germany. Lilly is the 10th largest pharmaceutical company in the world.
Springfondet is proud to welcome Kistefos as a new investor in Syntavit, and Mrs. Kimberly Lei as a new board member in the company, in the strong belief that both these developments will significantly strengthen Syntavit going forward.
